Kaiyi Zhang

Kaiyi Zhang

Auto-generated profile, based on publicly available information

Kaiyi Zhang

Institute of Medical Microbiology, RWTH Aachen University Hospital, Aachen, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KZKaiyi Zhang
Kaiyi Zhang
URUrska Repnik
Urska Repnik
NDNour Diab
Nour Diab
DFDaniel Friske
Daniel Friske
PPPuetz Puetz
Puetz Puetz
MHMathias W. Hornef
Mathias W. Hornef
The intestinal epithelium is the first line of defense against enteric pathogens. Removal of infected cells by exfoliation prevents mucosal translocation and systemic infection in the adult host, but is less commonly observed in the neonatal intestine. Instead, here, we describe non-professional efferocytosis of Salmonella-infected enterocytes by neighboring epithelial cells in the neonatal intestine. Intestinal epithelial stem cell organoid cocultures of neonatal and adult cell monolayers with damaged enterocytes replicated this observation, confirmed the age-dependent ability of intestinal epithelial cells for efferocytosis, and identified the involvement of the “eat-me” signals and adaptors phosphatidylserine and C1q as well as the “eat-me” receptors integrin-αv (CD51) and CD36 in cellular uptake. Consistent with this, massive epithelial cell membrane protrusions and CD36 accumulation at the contact site with apoptotic cells were observed in the infected neonatal host in vivo. Efferocytosis of infected small intestinal enterocytes by neighboring epithelial cells may represent a previously unrecognized mechanism of neonatal antimicrobial host defense to maintain barrier integrity.

17 February 2022 in Infection and Immunity
Verified
Journal Article
Closed access
LRLaura Robrahn
Laura Robrahn
ADAline Dupont
Aline Dupont
SJSandra Jumpertz
Sandra Jumpertz
KZKaiyi Zhang
Kaiyi Zhang
CHChristian Holland
Christian Holland
TCThorsten Cramer
Thorsten Cramer
Hypoxia-inducible transcription factor 1 (HIF-1) has been shown to enhance microbial killing and ameliorate the course of bacterial infections. While the impact of HIF-1 on inflammatory diseases of the gut has been studied intensively, its function in bacterial infections of the gastrointestinal tract remains largely elusive.

30 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SSStefan Schlößer
Stefan Schlößer
AUAnna-Lena Ullrich
Anna-Lena Ullrich
NMNastaran Fazel Modares
Nastaran Fazel Modares
Matthias A. SchmitzMatthias A. Schmitz
Matthias A. Schmitz
JSJohannes Schöneich
Johannes Schöneich
MHMathias W. Hornef
Mathias W. Hornef
Postnatal establishment of enteric metabolic, host–microbial and immune homeostasis is the result of precisely timed and tightly regulated developmental and adaptive processes. Here, we show that infection with the invasive enteropathogen Salmonella Typhimurium results in accelerated maturation of the neonatal epithelium with premature appearance of antimicrobial, metabolic, developmental, and regenerative features of the adult tissue. Using conditional Myd88-deficient mice, we identify the critical contribution of immune cell-derived mediators. Cytokine stimulation of neonatal intestinal epithelial stem cell organoids suggests a network of synergistic and antagonistic cytokine effects with a significant contribution of IL-22, IL-4/IL-13, TNF, and IL-6 to infection-induced enterocyte reprogramming. Our findings demonstrate that the infection-associated immune cell activation disrupts physiological postnatal tissue maturation and may thereby worsen clinical outcomes and alter the neonatal-adult transition.

6 July 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
NDNour Diab
Nour Diab
CYChiun Huei Yong
Chiun Huei Yong
ESEva-Lena Stange
Eva-Lena Stange
MBMarlène S. Birk
Marlène S. Birk
Matthias A. SchmitzMatthias A. Schmitz
Matthias A. Schmitz
MHMathias W. Hornef
Mathias W. Hornef
Salmonella enterica subsp. enterica serovar Typhimurium ( S . Typhimurium) manipulates cellular processes through the translocation of effector molecules into the host cell cytosol. Using a recently established neonatal S . Typhimurium infection model, we provide functional insights into how Salmonella outer protein B (SopB) suppresses early mucosal tissue inflammation and prolongs host survival. Mechanistically, SopB prevents a disintegrin and metalloprotease 17 (ADAM17) activation, plasma membrane translocation and the release of membrane-bound TNFα from enterocytes and reduces epithelial secretion of IL-18 via mTOR-controlled secretory autophagy. This abolishes the early epithelial transcriptional response and reduces immune cell recruitment and programmed cell death-mediated mucosal barrier disruption delaying disease progression. The immunosuppressive effect of SopB is independent of the C-terminally encoded phosphatidylinositol phosphatase and phosphotransferase activity but requires an intact N-terminal domain. Also, it is restricted to the neonatal mouse model characterised by Salmonella pathogenicity island (SPI)1 type 3 secretion system (T3SS)-dependent enterocyte invasion-driven mucosal translocation. Thus, here we demonstrate that SopB suppresses the early, post-transcriptional regulation of epithelial cytokine release in an inositol phosphatase-independent manner likely promoting pathogen transmission.

2 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NDNour Diab
Nour Diab
ESEva-Lena Stange
Eva-Lena Stange
CYChiun Huei Yong
Chiun Huei Yong
JDJörg Deiwick
Jörg Deiwick
MVMihael Vucur
Mihael Vucur
MHMathias W. Hornef
Mathias W. Hornef
Salmonella enterica subsp. enterica serovar Typhimurium ( S. Typhimurium) translocates effector molecules via its Salmonella pathogenicity island (SPI)1 encoded type 3 secretion system (T3SS) to induce internalization by intestinal epithelial cells and manipulate cellular responses. Among these effector molecules, the Salmonella outer protein B (SopB) was shown to possess phosphatidyl-inositol phosphatase activity and induce bacterial internalisation, promote cell survival, influence endosomal trafficking and alter host cell signalling. Using a neonatal S. Typhimurium infection model, we here show that SopB in vivo suppresses early epithelial chemokine expression, delays mucosal immune cell recruitment, reduces barrier impairment by enterocyte necroptosis, and prevents disease progression and premature death. Unexpectedly, this immunosuppressive effect was independent of the phosphatidyl-inositol phosphatase and phosphotransferase activity of SopB but required an intact N-terminal domain. Thus, SopB exerts a potent phosphatase-independent immunosuppressive effect to delay local tissue inflammation and disease progression likely to promote host transmission.

19 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMaria D. Chiotelli
Maria D. Chiotelli
CPCharlie Pauvert
Charlie Pauvert
NTNicole S. Treichel
Nicole S. Treichel
ESEva-Lena Stange
Eva-Lena Stange
KZKaiyi Zhang
Kaiyi Zhang
MGMarianne Grognot
Marianne Grognot
Swimming motility has long been studied as a virulence mechanism of enteric pathogens, while the resident microbiota’s motility has only been inferred from proxies or explored through a few model species. This study presents a direct, functional analysis of gut bacterial motility in health and inflammation. Using phase-contrast microscopy and high-throughput 3D tracking, we quantified motile bacteria and characterized their swimming behaviours directly in diluted fresh gut content. In healthy mice, fewer than 3% of bacteria were motile along the digestive tract, and their swimming patterns were dominated not by the run-tumble behavior of model gut species but by diverse behaviours rich in reverses. In five mouse models with intestinal inflammation (spanning chemical, genetic, dietary and infectious etiologies) the motile fraction rose by at least 4-fold, correlating with elevated Lipocalin-2 where measured. Reverse-rich patterns remained prevalent in these inflamed conditions, with the notable exception of Salmonella infection. Paired metagenomics and metatranscriptomics showed enrichment of flagellar genes, while communities transferred into cecal water from inflamed mice raised their motile fraction within an hour, indicating that the rise reflects both enrichment of motile taxa and rapid modulation within existing populations. In vitro assays with human-derived isolates confirmed motility across several phyla, with variability down to strain level, and identified oxygen and viscosity as key modulators. These findings support increased motility as a hallmark of the inflamed gut and challenge established assumptions about gut bacterial motility. Significance Statement: Several gut pathogens swim to survive and infect, but whether the trillions of resident bacteria also swim has only been inferred indirectly. We find that swimming is rare, under 3% of bacteria in fresh gut content. By 3D-tracking individual bacteria, we show that they swim unlike the run-tumble motility of Escherichia coli, the implicit model for gut bacterial motility since the 1970s. In five mouse models of intestinal inflammation, far more bacteria swim, from both enrichment of motile species and rapid switching within existing ones. How and when gut bacteria move, not just which are present, may matter in inflammatory diseases.